#drug pricing

Yes! The Mark Cuban Cost Plus Drug Company sells cheaper generic drugs for diabetes, cancer, high blood pressure, HIV and more.

AIDS United’s working group of safety net providers weighs in on ending the epidemic.

The documentary short “Right to Try” follows Jeffrey Drew as he participates in an experimental and controversial treatment to cure HIV.

AIDS United’s working group of safety-net providers advances health equity—with help from the federal 340B Discount Drug Program.

The availability of multiple, low-cost generic versions of PrEP should be good news for access. But will it be?

A letter from 124 patient groups urges the White House to make drugs more affordable—and spells out how it can do so.

The new Avita pharmacy specializes in services related to HIV, PrEP, LGBTQ issues and the 340B Drug Pricing Program.

Watch AIDS advocates urge the governor not to abandon efforts to combat HIV, hepatitis and opioid overdoses.

The first generic Truvada is now available in the United States.

Teva’s new version of TDF and emtricitabine doesn’t offer much of a price break, but that could come next spring.

Total payments for the HIV prevention pill exceeded $2 billion in 2018.

A new lawsuit accuses the imprisoned hedge funder of blocking generic rivals of an AIDS-related drug.

Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.

Oncologist wins Senate backing by a vote of 72 to 18.

“Overall, the candidates seemed well informed around HIV/AIDS issues.”

A look at what the law says about buying prescription drugs from Canada.